- United States
- /
- Healthcare Services
- /
- NasdaqCM:EUDA
EUDA Health Holdings Second Quarter 2023 Earnings: US$0.28 loss per share (vs US$1.86 loss in 2Q 2022)
EUDA Health Holdings (NASDAQ:EUDA) Second Quarter 2023 Results
Key Financial Results
- Revenue: US$1.11m (down 54% from 2Q 2022).
- Net loss: US$6.10m (loss widened by 228% from 2Q 2022).
- US$0.28 loss per share.
All figures shown in the chart above are for the trailing 12 month (TTM) period
EUDA Health Holdings shares are up 15% from a week ago.
Risk Analysis
You should always think about risks. Case in point, we've spotted 5 warning signs for EUDA Health Holdings you should be aware of, and 3 of them shouldn't be ignored.
Valuation is complex, but we're here to simplify it.
Discover if EUDA Health Holdings might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.
Access Free AnalysisHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
About NasdaqCM:EUDA
EUDA Health Holdings
Engages in the provision of non-invasive healthcare services primarily in Singapore, Malaysia, and China.
High growth potential with low risk.
Market Insights
Weekly Picks

Crazy Undervalued 42 Baggers Silver Play (Active & Running Mine)

Fiducian: Compliance Clouds or Value Opportunity?
Willamette Valley Vineyards (WVVI): Not-So-Great Value
Recently Updated Narratives

The "Molecular Pencil": Why Beam's Technology is Built to Win

ADNOC Gas future shines with a 21.4% revenue surge
Watch Pulse Seismic Outperform with 13.6% Revenue Growth in the Coming Years
Popular Narratives

MicroVision will explode future revenue by 380.37% with a vision towards success

NVDA: Expanding AI Demand Will Drive Major Data Center Investments Through 2026
